Dermatology Residency Program

Julian J. Trevino, M.D., Director

Dr. Nordland

James J. Nordlund, M.D.

Clinical Professor, Department of Dermatology
Wright State University Boonshoft School of Medicine
Wright State Dermatology
Wright State Physicians Building
725 University Blvd.
Dayton, Ohio 45435
Contact Dr. Nordland:
Patient Appointments: (937) 224-7546
Academic Calls: (937) 245-7254
Fax: (937) 267-7536

Education

1961

B.A., Philosophy, Magna cum Laude
St. John's University
Collegeville, Minnesota

1963

B.S., Medical Science
University of Minnesota
Minneapolis, Minnesota

1965

M.D., University of Minnesota
Minneapolis, Minnesota


Professional Career

1965 - 1966

Intern, Internal Medicine
Duke University
Durham, North Carolina

1966 - 1967

Resident, Internal Medicine
Duke University
Durham, North Carolina

1967 - 1969

Clinical Associate
Public Health Service
National Cancer Institute
Bethesda, Maryland

1969 - 1970

Resident, Internal Medicine
Yale University School of Medicine
New Haven, Connecticut

1970 - 1972

Resident, Dermatology
Yale University School of Medicine
New Haven, Connecticut

1972 - 1978

Assistant Professor, Dermatology
Yale University School of Medicine
New Haven, Connecticut

1972 - 1983

Attending Physician, Dermatology
Yale New Haven Hospital
New Haven, Connecticut

1972 - 1979

Physician
Yale University Health Service
New Haven, Connecticut

1975 - 1979

Dermatologist, Fair Haven Community Free Health Clinic
Fair Haven, Connecticut

1975 - 1979

Dermatology Consultant
American Hospital Formulary Service

1975 - 1983

Dermatology Consultant Hospice, Inc.
New Haven, Connecticut

1976 - 1983

Visiting Committee on Curriculum
St. John's University
Collegeville, Minnesota

1978 - 1982

Associate Professor, Dermatology
Yale University School of Medicine
New Haven, Connecticut

1979 - 1983

Chief of Dermatology
Yale University Health Service
New Haven, Connecticut

1982

Professor, Dermatology
Yale University School of Medicine
New Haven, Connecticut

1983 - 1998

Professor and Director, Dermatology
University of Cincinnati Medical Center
Cincinnati, Ohio

1998-1999

Consulting Dermatologist
Regional Dermatology Training Center
Kilimanjaro Christian Medical Center
Moshi, Tanzania

1998-2002

Professor of Dermatology
University of Cincinnati Medical Center
Cincinnati, Ohio

2002-present

Professor Emeritus
University of Cincinnati Medical Center
Cincinnati, Ohio

2002-present

Dermatologist
Group Health Associates
Cincinnati, Ohio

2004-2006

Clinical Professor of Dermatology
Wright State University Boonshoft School of Medicine
Dayton, OH


Professional Honors and Recognition

1963

AOA Honor Fraternity

1965

Lange Medical Publication Award for Scholastic Achievement

1972 - 1974

Dermatology Foundation Fellowship

1974 - 1977

Research and Education Associate, VA Medical Center

1977 - 1980

Clinical Investigator, VA Medical Center

1983

MA Yale University (Honorary)

1983

American Dermatological Association

1984

Noah Worcester Society

1993

Fellow of the Graduate School, University of Cincinnati

1993

Kung Sung Oh Memorial Lecturer, Yonsei University
Seoul Korea (September, 1993)

1996

Selected ' Best Doctors in America' by Woodward/White survey
(Aiken South Carolina)

1997

American Skin Association Award for Vitiligo Research
(with prize of $10,000)

1998

Career Achievement Award
PanAmerican Society for Pigment Cell Research
Aspen, Colorado

1998

Selected 'Best Doctors in America' by Woodward/White survey
(Aiken South Carolina)

2001

Luis E. Guerrera Lectureship: University of Santo Tomas,
Manila, Philippines

2002

Health Care Heros Award: Finalist Innovator Category

2001-2002

Selected 'Best Doctors in America' by Best Doctors, Inc.
(Aiken, South Carolina)

2002-2003

Distinguished Career Award in Science:
Alumni Association,
St. John's University, Collegeville, Minnesota

2005

International League of Dermatological Societies: Certificate of Appreciation for outstanding contributions to international Dermatology and pigment cell studies.

2006

Selected 'Best Doctors in America'


Professional Societies

American Dermatological Association
Noah Worcester Society
American Academy of Dermatology
Cincinnati Dermatological Society
International Federation of Pigment Cell Societies
Ohio Dermatological Association
Pan American Society for Pigment Cell Research


Patents

Use of ∝-MSH topically as an anti-inflammatory agent.
No. 4,874,744

Melanogenic Inhibitor
No. 5,719,126


Grants

1972 - 1974
-1972
-1973

Dermatology Foundation Fellowship, 15,000/year
Dermatology Foundation Fellowship, 15,000/year
Atypical Growth, $3,000

1974 - 1977

Research and Education Associate, $60,000/year

1977 - 1980

Clinical Investigatorship, $80,000/year

1979 - 1983

Vitiligo Center Grant (AM-25252), $35,000/year (co-investigator)

1983

Vitiligo Center Grant (AM-25252), $640,000 (co-investigator)

1983 - 1986

Vitiligo Center Grant, $110,000

1986 - 1989

NIAMD Vitiligo Center Grant (AM-25252), $305,000

1986 - 1988

Shriners Burns Institute, $127,000

1987 - 1990

NIOSH (R01 OH-O2091), $180,000

1988 - 1990

Procter & Gamble, $170,000

1988 - 1997

Avon Products, $200,000

1989 - 1992

National Vitiligo Foundation, $90,000

1989 - 1991

Shriners Burns Institute, $157,000

1990 - 1991

National Vitiligo Foundation, $30,000

1991 - 1993

Shriners Burns Institute, $216,000

1991 - 1993

Gelb Foundation, $105,000

1992 - 1993

National Vitiligo Foundation, $100,000

1992 - 1994

POLA Corporation, $100,000

1992 - 1994

The Procter & Gamble Company, $190,000

1994

The Procter & Gamble Company, $28,000

1994 - 1997

Shriners Burns Institute, $180,000

1995 - 1997

Alcon Laboratories, $150,000

1998

Ohio Dermatological Association $1000

1998

International Foundation for Dermatology $8000

2001

STTR from NIH $90,000 for preparation of a new skin lightening agent.


Commitees & Activities

National & Regional

1978 - 1983

Public Relations Committee, Society of Investigative Dermatology (Chairman, 1983)

1979

Committee on Tenure, Associate of Professors of Dermatology

1979 - 1988

Editorial Board, Dermatology Times

1983 - 1992

National Advisory Committee, St. John's University, Collegeville, MN

1984 - 1989

Board of Directors, Society of Investigative Dermatology

1984 - 1987

Committee on Research Activities, American Academy of Dermatology

1984 - Present

Scientific Program Committee, Chairman, Cincinnati Dermatologic Society

1985

Board of Trustees, National Organization of Albinism and Hypopigmentation

1986

Scientific Program Committee, Ohio Dermatologic Association

1986

Organizing Committee, Pan-American Pigment Cell Society

1986 - 1991

Associate Editor, Journal of Pigment Cell Research

1986 - 1989

Finance Committee, Society of Investigative Dermatology

1987

Guest Editor, Dermatologic Clinics

1987- present

Medical Advisory Board, National Vitiligo Foundation

1987 - 1997

Associate Editor (Pigmentation), Journal of Investigative Dermatology

1987 - 1991

Board of Directors, American Academy of Dermatology

1988 - 1991

President, Pan American Society for Pigment Cell Research (PASPCR)

1990- present

Editorial Board, Photodermatology, Photoimmunology & Photomedicine

1990-present

Editorial Board, Experimental Dermatology

1990 - 1993

Secretary/Treasurer, International Federation of Pigment Cell Societies

1992 - 1995

Scientific Review Committee: Dermatology Foundation

1989 - 1994

Long Range Planning Committee, American Academy of Dermatology

1992 - 1993

Member, Vision Committee; Section on Ethics, American Academy of Dermatology

1992 - 1997

Consultant, Arizona Program for Prevention of Melanoma and Other Skin Cancers

1992

Chairman for IVth Annual Meeting of PanAmerican Society for Pigment Cell Research, June 7-10, 1992, Cincinnati, Ohio

1992 - 1993

Scientific Chairman, Noah Worcester Dermatologic Society Meeting, La Costa, CA

1992 - 1995

Member of Scientific Advisory Committee and Study Section Dermatology Foundation

1993 - 1995

Editorial Board, Current Opinion in Dermatology

1993 - 1998

Editorial Board, Journal of the American Academy of Dermatology

1994 - 1995

President-Elect, Cincinnati Dermatological Society

1994 - 1997

Board of Directors, Cincinnati Dermatologic Society

1995 - 1996

President, Cincinnati Dermatological Society

1996 - 1998

Board of Directors, Noah Worcester Dermatologic Society

1996 - 1998

Secretary/Treasurer, Pan American Society for Pigment Cell Research

1996 - 2001

Judicial Committee, American Academy of Dermatology, Chairman 2001

1996 - 2000

Core Curriculum Committee, American Academy of Dermatology

1998-2002

Committee on International Affairs, American Academy of Dermatology

2000

Editor emedicine.com

2001-2004

Associate Editor, International Journal of Dermatology

2002-2005

Editorial Board, Journal American Academy of Dermatology

2003-2007

Judicial Committee, American Academy of Dermatology

2003-present

Surveyor for Accreditation Association for Ambulatory Health Care

2004-2008

Chair, Task Force Education Volunteers Abroad, American Academy of Dermatology

University & Local

1973 - 1975

Medical School Council, Yale University

1976 - 1978

Planning and Priorities, Yale University

1979 - 1983

Human Investigation Committee (Chairman), Yale University

1983

Board of Permanent Officers, Yale University

1984

Faculty Forum, Committee on Tenure, University of Cincinnati

1984

M.D./Ph.D. Study Committee, University of Cincinnati

1985

Chairman, By-Laws Committee, University Hospital

1986

Chairman, Neurology Review Committee, University of Cincinnati

1986

Chairman, Search Committee for Chairman of Department of Internal Medicine, University of Cincinnati

1987

Co-Chairman, Committee on Development of Faculty Tracks, University of Cincinnati

1987

Member, Committee on Development of University-Industrial Research, University of Cincinnati

1987

Chairman, Ad hoc Committee of Cincinnati Dermatological Society to Local HMO's regarding role of Dermatology in managed medical care

1988

Chairman, Planning Committee of Hospital Executive Committee, University of Cincinnat

1988 - 1990

Biomedical Science Research Grant Committee, University of Cincinnati

1988 - 1991

Integrating Curriculum Committee, University of Cincinnati College of Medicine

1988 - 1994

Steering Committee, University of Cincinnati College of Medicine

1988 - Present

AOA Committee

1988

President's Council on Race Relations & Human Decency, University of Cincinnati

1988 - 1992

Co-Chairman, MD/PhD Medical Scholars Program, University of Cincinnati College of Medicine

1989 - 1990

Ad hoc Committee to revise RPT criteria, University of Cincinnati College of Medicine

1994

Ethics Committee, University of Cincinnati

1994

Planning Committee, University of Cincinnati Hospital

1995

Chairman, LCME Study Section Committee, University of Cincinnati College of Medicine

2001

University Academic Appeals Board, University of Cincinnati

2001

Board of Directors: Institute for Learning in Retirement, University of Cincinnati

2004

Quality Improvement Committee, Group Health Associates

2004-2008

Chairman Education and Volunteers Abroad , American Academy of Dermatology

2006

Medical Director, Dermatology, Group Health Associates


Reviewer

Journal of Investigative Dermatology
Journal of the American Academy of Dermatology
Archives of Dermatology
Journal of Immunology
American Journal of Pathology
Journal of Clinical Investigation
Cancer Research
Science (occasional)
Photobiology and Photochemistry (occasional)
New England Journal of Medicine (occasional)
Cancer
International Journal of Dermatology
Journal Pigment Cell Research


Bibliograpy

Original Articles

Root R, Nordlund JJ, Wolff S: Factors affecting the quantitative production and assay of human leukocytic pyrogen. J Lab Clin Med 75:679'93, 1970.

Nordlund JJ, Wolff S, Levy H: Inhibition of biologic activity of Poly 1:Poly C by human plasma. Proc Soc Exp Biol Med 133:439'44, 1970.

Nordlund JJ, Root R, Wolff S: Studies on the origin of human leukocytic pyrogen. J Exp Med 131:727'43, 1970.

Canellos G, Nordlund JJ, Carbone P: Splenectomy for thrombocytopenia in chronic granulocytic leukemia. Cancer 29:660'65, 1972.

Nordlund JJ, Gershon R: Splenic regulations of the clinical appearance of small tumors. J Immunol 114:1486'90, 1975.

Nordlund JJ, Lerner AB: The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocr Metab 45:768'74, 1977.

Nordlund JJ, Anderson C, Hsiung GD, Tenser RB: The use of temperature sensitivity and selective cell culture systems for differentiation of herpes simplex virus type 1 and 2 in a clinical laboratory. Proc Soc Exp Biol Med 155:118'23, 1977.

Lerner AB, Nordlund JJ: Vitiligo. What is it? JAMA 239:1183'87, 1978.

Nordlund JJ, Ackles AE: Leukoderma in the nude C57BL/6 mouse. Br J Dermatol 99:395'400, 1978.

Porter J, Beuf A, Nordlund JJ, Lerner AB: Personal responses of patients to vitiligo: The importance of the patient-physician interaction. Arch Dermatol 114:1384'85, 1978.

Porter J, Beuf A, Nordlund JJ, Lerner AB: Psychological reaction to chronic skin disorders. A study of patients with vitiligo. Gen Hosp Psych 1:73'77, 1979.

August M, Nordlund JJ, Hsiung GD: Persistence of HSV'1 and HSV'2 in infected individuals. Arch Dermatol 115:309'10, 1979.

Albert DM, Nordlund JJ, Lerner AB: Ocular changes in vitiligo. In: Pigment Cell, Vol. 5, SN Klaus (ed), S. Karger, Basel, 1979. pp. 62'72.

Albert DM, Nordlund JJ, Lerner AB: Ocular abnormalities occurring with vitiligo. Ophthal­mology 86:1145'58, 1979.

Halaban R, Nordlund JJ, Franckeu J, Moellmann GE, Eisenstadt J: Supermelanotic hybrids derived from mouse melanomas and normal mouse cells. Somatic Cell Genetics 6:29'44, 1980.

Ratner L, Nordlund JJ, Lengyel P: Interferon as an inhibitor of cell growth: Studies with mouse melanoma cells. Proc Soc Exp Biol Med 163:267'72, 1980.

Nordlund JJ, Ackles AE, Gershon RK: Quantitative factors which determine the effect of the immune response on the growth rate of the Cloudman melanoma in the DBA/2 mice. Cell Immunol 56:258'72, 1980.

Nordlund JJ, Cone R, Gershon RK, Ackles AE: Studies on the release of surface proteins from Cloudman melanoma cells. Cell Immunol 56:273'85, 1980.

Mitchell M, Nordlund JJ, Lerner AB: Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi and melanoma. J Invest Dermatol 75:144'47, 1980.

Nordlund JJ, Ackles AE: A method for quantifying Langerhans cells in the epidermal sheets of human and murine skin. Tissue Antigens 17:217'25, 1981.

Nordlund JJ, Howanitz N, Bystryn JC, Forget BM, Lerner AB: Anti-pigment cell factors and mucocutaneous candidiasis. Arch Dermatol 117:210'12, 1981.

Nordlund JJ, Ackles AE, Traynor FF: The proliferative and toxic effects of ultraviolet light and inflammation on epidermal pigment cells. J Invest Dermatol 77:361'68, 1981.

Nordlund JJ, Ackles AE, Lerner AB: Effects of ultraviolet light and certain drugs on Ia-bearing Langerhans cells in murine epidermis. Cell Immunol 60:50'63, 1981.

Nordlund JJ, Todes-Taylor N, Albert DM, Wagner MD, Lerner AB: Prevalence of vitiligo and poliosis in patients with uveitis. J Am Acad Dermatol 4:528'36, 1981.

Howanitz M, Nordlund JJ, Lerner AB, Bystryn JC: Antibodies to melanocytes in patients with vitiligo. Arch Dermatol 117:705'708, 1981.

Bystryn JC, Howanitz N, Nordlund JJ, Lerner AB: Antibodies to melanocytes in patients with vitiligo. In: Pigment Cell, 1981: Phenotypic Expression in Pigment Cells, M Seiji (ed), University of Tokyo Press, Tokyo, Japan, 1981. pp. 483-488.

Scheibner A, Milton GW, McCarthy WH, Nordlund JJ, Pearson LJ: Multiple primary melanoma - a review of 90 cases. Austr J Dermatol 23:1'8, 1982.

Kirkwood JM, Ariyan S, Nordlund JJ, Forget BM: Granulomatous lymphangitis: A complication of intralymphatic MER therapy. Cancer 50:73'77, 1982.

Moellmann G, Klein-Angerer S, Scollay D, Nordlund JJ, Lerner AB: Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest

Dermatol 79:321'30, 1982.

Ariyan S, Kirkwood JM, Mitchell MS, Nordlund JJ, Lerner AB, Papac RJ: Intralymphatic and regional surgical adjuvant immunotherapy in high risk melanoma of the extremities. Annals Surg 92:459'63, 1982.

Nordlund JJ, Askenase PW: The effect of histamine, anti-histamines and a mast cell stabilizer on the growth of Cloudman melanoma cells in DBA/2 mice. J Invest Dermatol 81:28'31, 1983.

Albert DM, Wagoner MD, Pruett RC, Nordlund JJ, Lerner AB: Vitiligo and disorders of the retinal pigment epithelium. Br J Ophth 67:153'56, 1983.

Albert DM, Forget BM, Searl SS, Lavin PT, Kirkwood J, Nordlund JJ: Uveal profile in patients with cutaneous melanoma. Am J Ophth 95:474'79, 1983.

Nordlund JJ, Kirkwood J, Forget BM, Milton G, Lerner AB: Vitiligo in patients with metastatic melanoma: A good prognostic sign. J Am Acad Dermatol 9:689'95, 1983.

Nordlund JJ: Chemical agents which mimic the effects of ultraviolet radiation on the epidermis: A possible role for oxidation of arachidonic acid in expression of surface markers on epidermal cells. In: The Effect of Ultraviolet Radiation on the Immune System, J Parrish (ed), Johnson and Johnson, 1983. pp. 161'180.

Wagoner MD, Albert DM, Lerner AB, Kirkwood JM, Forget BM, Nordlund JJ: New observations on vitiligo and ocular disease. Am J Ophth 96:16'26, 1983.

Scheibner A, McCarthy WH, Milton GW, Nordlund JJ: Langerhans cell and melanocyte distribution in "normal" human epidermis. Austr J Dermatol 24:9'16, 1983.

Askenase PW, Loveren HV, Kraeuter-Kops S, Ron Y, Meade R, Theoharides TC, Nordlund JJ, Sovern H, Gershon MD, Ptak W: Deficient elicitation of delayed-type hypersensitivity in W/Wv and S1/S1d mast cell deficient mice. J Immunol 131:2687'94, 1983.

Goldgeier M, Klein LE, Klein-Angerer S, Moellman G, Nordlund JJ: The distribution of melanocytes in the leptomeninges of the human brain. J Invest Dermatol 82:235'39, 1984.

Nordlund JJ, Ackles AE: Melanocytotoxins and fatty acids which stimulate proliferation of melanocytes in murine pinnal epidermis: A possible role for arachidonic acid metabolism in regulation of melanocyte growth. In: Pigment Cell, 1985: Biological, Molecular and Clinical Aspects of Pigmentation, J Bagnara, SN Klaus, E Paul, M Schartl (eds), University of Tokyo Press, Tokyo, Japan, 1985. pp. 501-513.

Nordlund JJ, Kirkwood JM, Forget BM, Scheibner A, Albert DM, Lerner E, Milton GW: A demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 45:1855'61, 1985.

Nordlund JJ, Forget B, Kirkwood J, Lerner AB: Dermatitis produced by applications of monobenzone in patients with active vitiligo. Arch Dermatol 121:1141'45, 1985.

Nordlund JJ, Collins CE, Rheins LA: Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse. J Invest Dermatol 86:433'37, 1986.

Rheins LA, Palkowski MR, Nordlund JJ: Alterations in cutaneous immune reactivity to dinitrofluoro­benzene in graying C57BL/vivi mice. J Invest Dermatol 86:539'42, 1986.

Rheins LA, Nordlund JJ: Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity. J Immunol 136:867'876, 1986.

Porter JR, Beuf AH, Lerner A, Nordlund JJ: The psychosocial effect of vitiligo: A compari­son of vitiligo patients with "normal" controls, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 15:220'224, 1986.

Palkowski MR, Nordlund M, Rheins LA, Nordlund JJ: The distribution of Langerhans cells in hair follicles of normal C57BL/6 mice and graying C57BL/vitvit male mice. Arch Dermatol 123:1022'1028, 1987.

Rheins LA, Collins CE, Nordlund JJ: Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2. Cell Immunol 106:33'42, 1987.

Abdel-Malek Z, Swope VB, Amornsiripanitch N, Nordlund JJ: In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. Cancer Res 47:3141'46, 1987.

Rheins LA, Young EM, Nordlund ML, Berning RB, Amornsiripanitch N, Nordlund JJ: Rapid induction of Thy1 antigenic markers on keratinocytes and epidermal immune cells in skin of mice following topical treatment with common preservatives found in topical medica­tions and in foods. J Invest Dermatol 89:489'494, 1987.

Porter J, Beuf A, Lerner AB, Nordlund JJ: Response to cosmetic disfigurement: Patients with vitiligo. Cutis 39:493'494, 1987.

Amornsiripanitch S, Nordlund JJ, Barnes L, Trinkle L, Rheins LA: Immune studies in the depigmenting C57BL/Ler-vit/vit mice: An apparent isolated loss of contact hypersensitivity. J Immunol 140:3438'3445, 1988.

Nordlund JJ, Abdel-Malek ZA: Mechanisms for post-inflammatory hyperpigmen­tation and hypopigmentation. In: Advances in Pigment Cell Research, Proc XIII Interna­tional Pigment Cell Soc, J Bagnara (ed), Alan R. Liss, Inc., New York, 1988. pp. 219'236.

Roush GC, Nordlund JJ, Forget B, Gruber SB, Kirkwood JM: Independence of dysplastic nevi in determining risk for non-familial melanoma. Preventive Med 17:273'279, 1988.

Doherty NS, Rheins LA, Nordlund JJ: Multiple topical applications of arachidonic acid to mouse ears induce inflammatory and proliferative changes. J Invest Dermatol 91:298'­302, 1988.

Abdel-Malek ZA, Ross R, Pike JW, Trinkle L, Swope V, Nordlund JJ: Hormonal effects of vitamin D3 on epidermal melanocytes. J Cell Physiol 136:273'280, 1988.

Abdel-Malek ZA, Swope VB, Trinkle LS, Ferroni EN, Boissy RE, Nordlund JJ: Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a bromodeoxyuridine method of DNA analysis. J Cell Physiol 136:247'256, 1988.

Nordlund JJ, Amornsiripanitch S, Rheins LA, Abdel-Malek ZA, Boissy RE, Bell M: Role of the melanocyte in epidermal inflammatory and immune responses. Pigment Cell Res Suppl 1:101'112, 1988.

Trinkle LS, Swope VB, Abdel-Malek ZA, Nordlund JJ: Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium idodide. Cytometry 9:432'435, 1988.

Scheibner A, McCarthy WH, Nordlund JJ: Age and seasonal variation in melanocyte distribution in normal human epidermis. In: Cutaneous Aging, AM Kligman, Y Takase, BA Gilchrest, JJ Nordlund, SR Pinnell (eds), University of Tokyo Press, Tokyo, Japan, 1988. pp. 201'213.

Boissy RE, Gecks S, Smyth JR Jr, Nordlund JJ: Ocular pathology in the minimally depigmented subline of the vitiliginous Smyth chicken. Pigment Cell Res 5:303'314, 1988.

Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Sauder DN, Nordlund JJ: Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57BL/6 mice. J Invest Dermatol 93:511'517, 1989.

Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ: A new role for epidermal cell-derived thymocyte activating factor (ETAF)/IL'1 as an antagonist for distinct epidermal cell function. J Immunol 142:1943-­1949, 1989.

Abdel-Malek ZA, Swope VB, Trinkle LS, Nordlund JJ: Stimulation of Cloudman melanoma tyrosinase activity occurs predominantly in G2 phase of the cell cycle. Exp Cell Res 180:198'208, 1989.

Rheins LA, Moravec RA, Nordlund ML, Trinkle LS, Nordlund JJ: The role of antioxidants in skin immune reactions: The use of flow cytometry to determine alterations in Ia positive epidermal cells in allergic contact dermatitis. J Cosmet Sci 40:101'107, 1989.

Boissy RE, Trinkle LS, Nordlund JJ: Separation of pigmented and amelanotic melanocytes and the concomitant evaluation of endogenous peroxide content using flow cytometry. Cytometry 10:779'787, 1989.

Porter JR, Beuf AH, Lerner AB, Nordlund JJ: The effect of vitiligo on sexual relationship. J Am Acad Dermatol 22:221'222, 1990.

Boissy RE, Trinkle LS, Nordlund JJ: Neural tube derived melanocyte subsets undergo commitment to their distinct lineages in culture. Cell Diff Dev 30:129'145, 1990.

Quevedo WC, Holstein TJ, Dyckman J, Nordlund JJ: Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice. Pigment Cell Res 30:71'79, 1990.

Medrano EE, Nordlund JJ: Successful culture of adult human melanocytes from normal and vitiligo donors. J Invest Dermatol 95:441'445, 1990.

Swope VB, Abdel-Malek ZA, Kassem L, Nordlund JJ: Interleukins 1a and 6 and tumor necrosis factor-a are paracrine inhibitors of human melanocyte proliferation and melano­genesis. J Invest Dermatol 96:108'185, 1991.

Agarwal R, Medrano EE, Khan IU, Nordlund JJ, Mukhtar H: Metabolism of benzo(A)pyrene by human melanocytes in culture. Carcinogenesis 12:1963'1966, 1991.

Boissy RE, Beato KE, Nordlund JJ: Dilated rough endoplasmic reticulum and premature death in melanocytes cultured from the vitiligo mouse. Am J Pathol 138:1511'1525, 1991.

Boissy RE, Liu Y-Y, Medrano EE, Nordlund JJ: Structural aberration of the rough endoplas­mic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol 97:395'404, 1991.

Fivenson DP, Rheins LA, Nordlund JJ, Pomaranski M, Douglass MC, Krull EA: Thy'1 and T-cell receptor antigen expression in mycosis fungoides and benign inflammatory dermato­ses. J Natl Cancer Inst 83:1088'1092, 1991.

Abdel-Malek ZA, Swope VB, Pallas J, Krug K, Nordlund JJ: Mitogenic, melanogenic and cAMP response of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol 150:416'425, 1992.

Chetty BV, Boissy RE, Warden GD, Nordlund JJ: Basement membrane and fibroblast aberration in blisters at the donor, graft and spontaneously healed sites in burn patients. Arch Dermatol 128:181-186, 1992.

Lamoreux ML, Boissy RE, Wozniak JE, Nordlund JJ: The vit gene maps to the Mi (Mi­crophthalmia) locus of the laboratory mouse. J Hered 83:435-439, 1992.

Boyce ST, Medrano EE, Abdel-Malek Z, Supp AP, Dodick JM, Nordlund JJ, Warden GD: Pigmentation and inhibition of wound contraction by cultured skin substitutes with adult melanocytes after transplantation to athymic mice. J Invest Dermatol 100:360-365, 1993.

Medrano EE, Farooqui JZ, Boissy RE, Boissy YL, Akadiri B, Nordlund JJ: Chronic growth-stimulation of human adult melanocytes by inflammatory mediators in vitro: Implications for nevi formation and initial steps in melanocyte oncogenesis. Proc Natl Acad Sci USA 90:1790-1794, 1993.

Majumder P, Nordlund JJ, Nath SK: Pattern of familial aggregation of vitiligo. Arch Derma­tol 124:994-998, 1993.

Searle EA, Austin LM, Boissy YL, Zhao H, Nordlund JJ, Boissy RE: Smyth chicken melanocyte autoantibodies: Cross-species recognition, in vivo binding, and plasma membrane reactivity of the antiserum. Pigment Cell Res 6:145-157, 1993.

Farooqui JZ, Auclair BW, Robb E, Sarkisian E, Cooper C, Alexander JW, Warden G, Boissy RE, Nordlund JJ: Histological, biochemical, and ultrastructural studies on hyperpigmented human skin xenografts. Pigment Cell Res 6:226-233, 1993.

Spritz RA, Holmes SA, Berg SZ, Nordlund JJ, Fukai K: A recurrent deletion in the KIT (mast/stem cell growth factor receptor) proto-oncogene is a frequent cause of human piebaldism. Hum Mol Genet 2:1499-1500, 1993.

Boissy RE, Boissy YL, Krakowsky JM, Lamoreux ML, Lingrel JB and Nordlund JJ. Ocular pathology in mice with a transgenic insertion at the microphthalmia locus. J Submicro­scop Cytol Pathol 25:319-332, 1993.

Abdel-Malek Z, Swope V, Boissy R, Zhao H, Nordlund JJ: Contribution of melanogenic enzymes to the heterogeneous pigmentation of human melanocytes. J Cell Sci 106:1323-1331, 1993.

Farooqui J, Medrano EE, Abdel-Malek Z, Nordlund JJ: The expression of proopiomelanocortin (POMC) and various POMC-derived peptides in mouse and human skin. Ann NY Acad Sci 680:508-510, 1993.

Medrano EE, Yang F, Boissy R, Farooqui J, Shah V, Matsumoto K, Nordlund JJ, Park H-Y: Terminal differentiation and senescence in the human melanocyte: Repression of tyrosine-phosphorylation of the extracellular-signal regulated kinase 2 (ERK2) selectively defines the two phenotypes. Mol Biol Cell 5:497-509, 1994.

Swope VB, Sauder DN, McKenzie RC, Sramkoski RM, Krug KA, Babcock GF, Nordlund JJ, Abdel-Malek ZA: Synthesis of interleukin-1a and interleukin-1b by normal human melanocytes. J Invest Dermatol 102:749-753, 1994.

Zhao H, Boissy YL, Abdel-Malek Z, King RA, Nordlund JJ, Boissy RE: On the analysis of the pathophysiology of Chediak-Higashi syndrome: Defects expressed by cultured melanocytes. Lab Invest 71:25-34, 1994.

Zhao H, Zhao Y, Nordlund JJ, Boissy RE: Human TRP-1 has tyrosine hydroxylase but not DOPA oxidase activity. Pigment Cell Res 7:131-140, 1994.

Abdel-Malek ZA, Swope VB, Medrano EE, Nordlund JJ: Proliferation and phenotypic expression of human melanocytes in vitro are affected by age, anatomical site and culture conditions. Pigment Cell Res 7:116-122, 1994.

Nath SK, Majumder PP, Nordlund JJ: Genetic epidemiology of vitiligo: Multilocus recessivity cross-validated. Am J Hum Genet 55:981-990, 1994.

Zhao H, Medrano EE, Nordlund JJ, Boissy RE: Nonradioactive northern analysis of melanoma total RNA using the S&S psoralen/biotin labeling and detection system. Schleicher & Schuell Sequences 44:1-3, 1994.

Abdel-Malek Z, Swope V, Smalara D, Babcock G, Dawes S, Nordlund JJ: Analysis of the UV-Induced Melanogenesis and Growth Arrest of Human Melanocytes. Pigment Cell Res 7:326-332, 1994.

Nordlund JJ, Csato M, Babcock G, Takei F: Low ICAM'1 expression in the epidermis of depigmenting C57BL/6J-mivit/mivit mice: A possible cause of muted contact sensitization. Exp Dermatol 4:20-29, 1995.

Ford D, Bliss JM, Swerdlow AJ, Armstrong BK, Franceschi S, Green A, Holly EA, Mack T, MacKie RM, Østerlind A, Walter SD, Peto J, Easton DF, and Nordlund JJ and others as collaborators: Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 62:377-381, 1995.

Farooqui JZ, Medrano EE, Boissy RE, Tigelaar RE, Nordlund JJ: Thy-1+ dendritic cells express truncated form of POMC mRNA. Exp Dermatol 4:297-301, 1995.

Farooqui J, Robb E, Warden G, Nordlund JJ: The isolation of a unique melanogenic inhibitor from human skin xenografts: Initial in vivo and in vitro characterization. J Invest Dermatol 104:739, 1995.

Nath SK, Nordlund JJ, Majumder PP: Pedigree analysis of vitiligo: further support for multilocus involvement. J Genet 74:41-46, 1995.

Boissy RE, Zhao H, Oetting WS, Austin LM, Wildenberg SC, Boissy YL, Zhao Y, Sturm RA, Hearing VJ, King RA, Nordlund JJ: Mutation in and lack of expression of tyrosinase related protein-1 (TRP-1) in melanocytes from an individual with tyrosinase-positive oculocutaneous albinism: A new subtype of albinism classified as OCA3. Am J Hum Genet 58:1145-1156, 1996.

Matsumoto K, Robb E, Warden G, Nordlund JJ: Hyperpigmentation of human skin grafted onto athymic nude mice: immunohistochemical study. Br J Dermatol 135:412-418, 1996.

Suzuki I, Cone RD, Im S, Nordlund JJ, Abdel-Malek ZA: Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137:1627-1633, 1996.

Nordlund JJ: Psychosocial effects of vitiligo and the failure of the medical profession. Loss Grief & Care, Vol. 7, No. ¾, pp. 113-120, 1996.

Nath SK, Nordlund JJ, Majumder PP: Pedigree Analysis of Vitiligo: Further Support for Multilocus Involvement. Accepted Journal of Genetics, 1996.

Nordlund JJ, Majumder PP: Recent Investigations on Vitiligo Vulgaris. Dermatologic Clinics 15(1):69-78, 1997.

Nordlund JJ: The epidemiology and genetics of vitiligo. Clin Dermatol 15:875-8, 1997.

Matsumoto K, Robb E, Warden G, Nordlund JJ: The expression of cytokines, growth factors and ICAM-1 in the healing of human cutaneous xenografts on nude mice; possible role of melanocytes in wound healing. Exp Dermatol 6:13-21, 1997.

Suzuki I, Tada A, Ollmann MM, Barsh GS, Im S, Lamoreux ML, Hearing VB, Nordlund JJ, Abdel-Malek ZA: Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to a-melanotropin. J Invest Dermatol 108:838-842, 1997.

Tada A, Suzuki I, Im S, Davis MB, Cornelius J, Babcock G, Nordlund JJ, Abdel-Malek ZA: Endothelin-1 is a paracrine factor that modulates melanogenesis of human melanocytes and participates in their response to ultraviolet light. Cell Growth Diff 9:575-584, 1998.

Can G, Abdel-Malek Z, Porter-Gill PA, Gill P, Boyce S, Grabowski GA, Nordlund JJ, Farooqui J. Identification and sequencing of a putative variant of proopiomelanocortin in human epidermis and epidermal cells in culture. J Invest Dermatol 111:485-491, 1998.

Im S, Moro O, Peng F, Medrano EE, Cornelius J, Babcock G, Nordlund JJ, Abdel-Malek ZA: Activation of the cAMP pathway by a-melanotropin mediates the response of human melanocytes to UVB radiation. Cancer Res 58:47-54, 1998.

Tripathi RK, Flanders DJ, Young TL, Oetting WS, Ramaiah A, King RA, Boissy RE, Nordlund JJ: Microphthalmia-Associated Transcription Factor (MITF) Locus lacks Linkage to Human Vitiligo or Osteopetrosis: An Evaluation. Pigment Cell Res: 12, 187-192, 1999.

Matsubayashi T, Sakaeda, T, T Kita, M Nara, Y Funasaka, M Ichihashi, T Fujita, F Kamiyama, A Yamamoto, JJ Nordlund, K Okumura. Pharmaceutical and clinical assessement of hydroquine ointment prepared by extemporaneous nonsterile compounding. Biol Pharm Bull: 25, 92-96, 2002

Effects of various storage conditions and alterations of antioxidant contents on chromatic aberratin of hydroquinone ointment. T matsubayashi, T Sakaeda, T Kita, T. Nakamura, M. Kakumoto, Y Funasaka, M Ichihashi, T Fujita, F Kamiyama,, A Yamamoto, JJ Nordlund, M Kaneko, A Iida, and K Okumura. Biol Pharm Bull:26, 120-122, 2003.

Books and Monographs

Nordlund JJ, Flesch L: A Dermatology Resource Manual & Training Guide. Procter & Gamble Co., Cincinnati, Ohio, 1988.

Nordlund JJ (ed). Dermatologic Clinics. Pigmentary Disorders, Vol 6. WB Saunders Co., Philadelphia, PA, 1988.

Kligman A, Tahase Y and associated editors Gilchrest B, Nordlund JJ, Pinnell S (eds). Cutaneous Aging, University of Tokyo Press, Tokyo, Japan , 1988.

Nordlund JJ, Ortonne JP: Vitiligo and depigmentation. In: Current Problems in Dermatology, Vol IV, WL Weston, RM MacKie, TT Provost (eds), Mosby-YearBook, Inc., St. Louis, 1992. pp. 3-30.

Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P (eds). The Pigmentary System: Physiology and Pathophysiology. Pp 1198. Oxford University Press, New York, NY. 1998.

Hann SK, Nordlund JJ. Vitiligo: Basic and Clinical Science. Pp 297 Blackwell Scientific Press. London. March 2000.

Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting W, Ortonne J-P (eds). The Pigmentary System: Physiology and Pathophysiology. Edition 2. Blackwell Scientific Publishers, London England . pp 1245 2006

Case Reports

Nordlund JJ, DeVita V, Carbone P: Severe vinblastine-induced leukopenia during late pregnancy with delivery of a normal infant. Ann Int Med 69:581'82, 1968.

Nordlund JJ, Klaus SN: Successful topical treatment of an unusual ulcer with fluorouracil. Arch Dermatol 106:390'91, 1972.

Nordlund JJ, Lerner AB, Braverman IM, McGuire J: Multiple lentigines syndrome: A case study. Arch Dermatol 107:259'61, 1973.

McGuire J, Nordlund JJ: Bullous disease of childhood. Arch Dermatol 108:284, 1973.

Nordlund JJ, Klaus SN, Mathews-Roth M: New therapy for polymorphous light eruption. Arch Dermatol 108:710'12, 1973.

Nordlund JJ, Lerner AB: On the cause of acanthosis nigricans. N Engl J Med 293:200, 1975.

Lerner AB, Nordlund JJ, Albert DM: Clinical appearance of cutaneous melanomas. Yale J Biol Med 48:403-407, 1975.

Nordlund JJ, Klaus SN, Gino J: Hypomelanosis of Ito. Acta Dermatol Venereol 57:261'­64, 1977.

Nordlund JJ, Hartley C, Fister J: On the cause of green hair. Arch Dermatol 113:1700, 1977.

Lerner AB, Nordlund JJ, Albert DM: Pigment cells of the eyes in people with vitiligo [letter]. N Engl J Med 296:232, 1977.

Walters J, Lerner AB, Nordlund JJ: Vitiligo, chronic thrombocytopenia, and autoimmune hemolytic anemia. Arch Dermatol 114:1366'67, 1978.

Nordlund JJ: Disorders of hypopigmentation. Conn Med 42:227'30, 1978.

Lerner AB, Nordlund JJ: Vitiligo: Loss of pigment in skin, hair and eyes. Jpn J Dermatol 5:1'8, 1978.

Nordlund JJ, Lerner AB, Miller LH, Kenney J: Proceedings of the First International Workshop on Vitiligo. J Invest Dermatol 71:165'66, 1978.

Lerner AB, Nordlund JJ: The appearance and etiology of common skin cancers. PA Journal 8:74'78, 1978.

Nordlund JJ, Albert DM, Forget BM, Lerner AB: Halo nevi and the Vogt-Koyanagi-Harada syndrome: Manifestations of vitiligo. Arch Dermatol 116:690'92, 1980.

Albert DM, Todes-Taylor M, Wagoner M, Nordlund JJ, Lerner AB: Vitiligo or halo nevi occurring in two patients with a choroidal melanoma. Arch Dermatol 118:34'36, 1982.

Goldgeier M, Nordlund JJ, Lucky A, Sibrack LA, McCarthy MJ, McGuire J: Hydroa vacciniforme: Diagnosis and therapy. Arch Dermatol 118:588'592, 1982.

Mallory S, Nordlund JJ: Waardenburg's syndrome with Hirschsprung's disease: A neural crest defect. J Pediatr Dermatol 3:119'124, 1986.

Barnes L, Nordlund JJ: Natural history of dysplastic nevi. Arch Dermatol 123:1059'1061, 1987.

Fivenson D, Melvin D, Nordlund JJ: Mixed viral and fungal skin lesions in a heart trans­plant recipient. J Am Acad Dermatol 19:1120'1121, 1988.

Belz JL, Breneman DL, Nordlund JJ: Successful treatment of cutaneous manifestations of Reiters syndrome in an AIDS patient. J Am Acad Dermatol 20:898'903, 1989.

Milton GP, Peck GL, Fu J-JL, DiGiovanna JJ, Nordlund JJ, Thomas JH, Sanders SF: Exacerbation of Darier's disease with lithium carbonate. J Am Acad Dermatol 23:926'­928, 1990.

Orme RL, Nordlund JJ, Barich L, Brown T: The MAGIC syndrome (Mouth And Genital ulcers with Inflamed Cartilage). Arch Dermatol 126:940'944, 1990.

Zabriskie NA, Nordlund JJ, Nerad JA: Unusual skin depigmentation following eyelid cryosurgery. Ophthal Plas Recontruct Surg 12(4):296-298, 1996.

Adams Brian B, Mutasim DF, Nordlund JJ. Steatocystoma Multiplex: a quick removal technique. Cutis: 64, 127-130, 1999

Twersky, J and JJ Nordlund: Cutaneous T Cell lymphoma sparing lesions of resolving herpes zoster. J Am Acad Dermatol: 51, 123-6.

Popular Reports

Nordlund JJ. A New Sherlockian Mystery: A little, white error. The Spectator 1: 4-5, 1999.

Nordlund, JJ. A Little White Error. The Formulary: The Journal for the Friends of Dr. Watson. Issue 8, pp 32-34, June, 2000, Hertfordshire, England .

Nordlund, JJ. A Visit to Eden. Living and Working in Tanzania . J Amer Acad Dermatol. 43: 1101-1108, 2000.

Nordlund, JJ. Mary F. Nordlund. Una visita al Ed'n. Dermatolo'ia Argentina Suppl: Diciembre pp 365-371, 2001.

Nordlund, JJ. An Ode to Godfrey Elmsworth, the Blanched Soldier and Friends. The Spectator 4: p 6, April, 2002.

Nordlund, JJ. A Treasure Trove of Sherlockiana. The Spectator 4: p 7, April 2002.

Nordlund, JJ. A Tribute to Sir James Saunders, The Spectator 5: p 2, April 2003

Reviews, Chapters

Nordlund JJ, Lerner AB: Vitiligo. In: Clinical Dermatology, J Demis, R Crounse, R Dobson, J McGuire (eds), Harper and Row, Vol 2, Section 11'33, 1972. pp. 1'12.

Nordlund JJ, Masters R: Amyloidosis. In: Clinical Dermatology, J Demis, R Crounse, J McGuire (eds), Harper and Row, New York, 1972. Vol 2, Section 12:21, pp. 1'9.

Lerner AB, Nordlund JJ: Use of melatonin in human subjects. In: Frontiers of Pineal Physiology, M Altshule (ed), MIT Press, Cambridge, Massachusetts, 1975. pp. 42'44.

Nordlund JJ: The clinical appearance of cutaneous melanomas. Yale J Biol Med 48:403'­07, 1975.

Nordlund JJ, Lerner AB: Melanoma, fascinating tumors. Conn Med 41:414'17, 1977.

Lerner AB, Nordlund JJ: Should vitiligo be induced in patients after resection of primary melanoma? Arch Dermatol 113:321, 1977.

Nordlund JJ, Lerner AB: On the causes of melanomas. Am J Pathol 89:443'48, 1977.

Nordlund JJ (Medical Editor): Internal Medicine: PreTest Self-Assessment and Review. PreTest Service, Inc., Blakiston Publications, McGraw-Hill Book Co., Wallingford, CT, 1977.

Nordlund JJ (Medical Editor): Internal Medicine: Patient Management Cases: PreTest Self-Assessment and Review. PreTest SErvice, Inc., McGraw-Hill Book Co., Wallingford, CT, 1977.

Nordlund JJ: Dermatology Medicine: Pretest Self Assessment and Review. McGraw-Hill Book Co., 1978.

Nordlund JJ: Disorders of hypopigmentation. Conn Med 42:227'230, 1978.

Lerner AB, Nordlund JJ: Melatonin: Clinical pharmacology. J Neural Trans Suppl 13:339'347, 1978.

Nordlund JJ, Lerner AB: Vitiligo: Its relationship to systemic disease. In: Dermatology Update, Elsevier, North Holland, 1979. pp. 411'432.

Nordlund JJ, Lerner AB: Vitiligo. In: Clinical Dermatology, J Demis, R Crounse, R Dobson, J McGuire (eds), Harper and Row, Vol 2, Section 11'33, 1979. pp. 1'12.

Kirkwood J, Tonkonow B, Nordlund JJ, Ariyan S, Forget BM, Lerner AB: Melanoma: A multi-disciplinary overview of current concepts and management. Conn Med 44:21'26, 1980.

Krown SE, Burk M, Kirkwood JM, Kerr D, Nordlund JJ, Morton DL, Oettgen HF: The American Cancer Society clinical trial of human leukocyte interferon in malignant melanoma: Preliminary results. In: Biology of Interferon System, E Demaeyer, G Galasso, H Schellekens (eds), Bio Medical Print, Elsevier, North Holland, 1981. pp. 397'400.

Lerner AB, Nordlund JJ: Vitiligo: Its status in 1980. In: Phenotypic Expression in Pigment Cells, M Seiji (ed), University of Tokyo Press, Tokyo, Japan, 1981. pp 441'444.

Fitzpatrick T, Lerner AB, Nordlund JJ, Anderson RR, Szabo G, Garcia RI, Prata G: Introduction to dermal pigment biology and dermal pigmentary disorders (ceruloderma): Significance, physical basis, cytologic and biochemical basis. In: Biology and Diseases of Dermal Pigmentation, TB Fitzpatrick, et al (eds), University of Tokyo Press, Tokyo, Japan, 1981. pp. 3'18.

Nordlund JJ: Vitiligo. In: Dialogues in Dermatology. Am Acad Dermatol, 1981.

Nordlund JJ: Genetic basis of pigmentation and disorders of pigmentation. In: Pathology of Malignant Melanoma, AB Ackerman (ed), Masson Publishers, New York, NY, 1981. pp. 23'47.

Klein L, Nordlund JJ: Genetic basis of pigmentation and its disorders. Int J Dermatol 20:621'631, 1981.

Bystryn JC, Howanitz J, Nordlund JJ, Lerner AB: Antibodies to melanocytes in patients with vitiligo. In: Pigment Cell, XIth International Pigment Cell Conference, M Seiji (ed), University of Tokyo Press, Tokyo, Japan, 1981. pp. 483'91.

Nordlund JJ, Lerner AB: Vitiligo: It is important. Arch Dermatol 118:5'8, 1982.

Goldgeier MH, Nordlund JJ, Lucky AW: Reproduction of hydroa vacciniforme with UVA. J Am Acad Dermatol 9:279-280, 1983.

Nordlund JJ: Vitiligo: A reconsideration of its manifestations and pathogenesis. In: Pathogenesis of Skin Disorders, B Thiers, R Dobson (eds), Churchill Livingstone, New York, NY, 1985. pp. 97'129.

Susong R, Nordlund JJ: Vitiligo, a guide to successful therapy. Drug Therapy 15:133'140, 1985.

Lucky PA, Nordlund JJ: The biology of the pigmentary system and its disorders. In: Dermatologic Clinics. Symposium on Melanoma and Pigmented Lesions, DS Rigel, RJ Freidman (eds), WB Saunders, Co., Philadelphia, PA, 1985. pp. 197'217.

Nordlund JJ: Pigmentary system in host defenses. In: Experimental and Clinical Photoimmunology, Vol. III, R Daynes, G Krueger (eds), CRC Press, 1985. pp. 189-202.

Nordlund JJ: The pigmentary system; a re-evaluation. Jpn J Derm 12:9'14, 1985.

Nordlund JJ: How melanomas arise in the skin. Skin Cancer Foundation J, 1985.

Nordlund JJ, Sober A, Hansen T: Periodic synopsis on pigmentation. J Am Acad Dermatol 12:359'363, 1985.

Nordlund JJ: Lives of pigment cells. In: Dermatologic Clinics, The Aging Skin, B Gilchrest (ed), WB Saunders Co., Philadelphia, PA, 1986. pp. 407'419.

Cline J, Nordlund JJ: Management of vitiligo in children. J Ped Derm 3:498'510, 1986.

Rheins LA, Nordlund JJ: Melanoma and immunity. In: Immune Mechanisms in Cutaneous Disease, D Norris (ed), Marcel Dekker, Inc., New York, New York, 1986. pp. 769'788.

Grimes PE, Kelly AP, Cline DJ, Nordlund JJ, Jareatt MT, Rogers M, Treadwell PA, Burgdorf WH, Kenney JA Jr: Management of vitiligo in children. Pediatr Dermatol 3:498-510, 1986.

Mallory SB, Wiener E, Nordlund JJ: Waardenburg's syndrome with Hirschsprung's disease: a neural crest defect. Pediatr Dermatol 3:119-124, 1986.

Barnes L, Nordlund JJ: Vitiligo. In: Clinical Dermatology, J Demis, R Crounse, R Dobson, B Thiers (eds), Harper & Row, 1987. Section 11'33, pp. 1'14.

Cline J, Nordlund JJ: Vitiligo. In: Common Problems in Dermatology, K Greer (ed), Yearbook Medical Publishers, Chicago, IL, 1987. pp. 421'430.

Barnes L, Nordlund JJ: Vogt-Koyanagi-Harada Allezendrini syndrome. In: Clinical Dermatology, J Demis, R Crounse, R Dobson, B Thiers (eds), Harper & Row, 1987. Section 11'34, pp. 1'4.

Nordlund JJ: Hypopigmentation, vitiligo and melanoma (editorial). Arch Dermatol 123:1005'1008, 1987.

Nordlund JJ: Melanomas and nevi. Ohio Medicine 83:781'785, 1987.

Nordlund JJ: Post-inflammatory pigmentation. Dermatol Clinics 6:185'192, 1988.

Nordlund JJ: Melanocyte stimulating hormone. In: Dialogues in Dermatology, M O'Donohue (ed), J Am Acad Dermatol, Vol. 22, 1988.

Barnes LM, Nordlund JJ: Depigmentation: Its significance in patients with melanoma. In: Clinics in Dermatology, Vol 7, R Mackie (ed), JR Lippincott, Philadelphia, 1989. pp. 66'79.

Amornsiripanitch S, Nordlund JJ: Hypopigmentation (Leukoderma). In: Clinical Dermatology, Vol 2. J Demis, R Crounse, R Dobson, J McGuire (eds), Harper & Row, 1989. Unit 11'25, pp. 1'7.

Young E, Nordlund JJ: Basic biology of the pigmentary system. In: Clinical Dermatology, Vol 2. J Demis, R Crounse, R Dobson, J McGuire (eds), Harper & Row, 1989. Unit 11'0, pp. 1'12.

Nordlund JJ, Abdel-Malek ZA, Boissy RE, Rheins LA: Pigment cell biology: An historical review. J Invest Dermatol 92(suppl):53s'60s, 1989.

Nordlund JJ, Lorton C: Disorders of pigmentation. In: Dermatology, M Orkin, M Dahl, H Maibach (eds), Appleton & Lange, 1989, Chap. 22, pp. 261'294.

Nordlund JJ, Young E: What is vitiligo? The Pharmacy 13:26, 1989.

Nordlund JJ: The lives of pigment cells. In: Clinics in Geriatric Medicine, Vol 5, B Gilchrest (ed), WB Saunders Co., Philadelphia, PA, 1989. pp. 91'108.

Roberts CN, Nordlund JJ: Corrective cover or camouflage clinic. (Letter) Ear, Nose & Throat J 68:481'82, 1989.

Lorton C, Nordlund JJ: Pigmentary disorders. In: Conn's Current Therapy, RE Rakel (ed), WB Saunders Company, Philadelphia, 1990. pp. 767-771.

Nordlund JJ, Halder R: Melagenina. An analysis of published and other available data. Dermatologica 181:1'4, 1990.

Kleier R, Nordlund JJ: Color variations of the iris. In Clinical Dermatology, Section 11-30, J Demis (ed), JB Lippincott, Philadelphia, 1991. pp. 1-5.

Lorton C, Nordlund JJ: Piebaldism, Waardenburg's syndrome and variants. In Clinical Dermatology, Section 11-27, J Demis (ed), JB Lippincott, Philadelphia, 1991. pp. 1-5.

Lorton C, Nordlund JJ: Miscellaneous disorders of hypopigmentation. In Clinical Dermatology, Section 11-29, J Demis (ed), JB Lippincott, Philadelphia, 1991. pp. 1-3.

Hoppenjans WB, Fu J, Nordlund JJ: Albinism. In Clinical Dermatology, Section 11-26, J Demis (ed), JB Lippincott, Philadelphia, 1991. pp. 1-14.

Daddabbo J, Nordlund JJ: Pigmentary abnormalities of the nails. In Clinical Dermatology, J Demis (ed), JB Lippincott, Philadelphia, 1991.

Nordlund JJ, Boissy RE, Abdel-Malek ZA, Swope VB: Biology of the Pigmentary System. An audiovisual program in basic science for dermatologists. Marvin B. Sulzberger Institute and The American Academy of Dermatology. 1991.

Nordlund JJ: Science for the Dermatologist. Column for Ohio Dermatological Association quarterly newsletter, 1991.

Nordlund JJ: The modern era for pigment cell research and the new International Federation of Pigment Cell Societies. Pigment Cell Res 4:1, 1991.

Nordlund JJ: a-Melanocyte-stimulating hormone. A ubiquitous cytokine with pigmenting effects. JAMA 266:2753'2754, 1991.

Geronemus RG, Grimes PE, Nordlund JJ, Wiley MD: Hypopigmentation: Serious or benign? Patient Care 25:57'78, 1991.

Geronemus RG, Grimes PE, Nordlund JJ, Wiley MD: What to look for in hyperpigmentation. Patient Care 25:47'72, 1991.

Nordlund JJ, Grimes P, Halder R: Vitiligo: An update on pathogenesis and treatment. Audiotape program for the American Academy of Dermatology. Produced by National AudioVideo Inc., 1992.

Nordlund JJ: Introduction to the biology of the pigment system. In Dermatology, S Moschella, H Hurley (eds), WB Saunders Company, Philadelphia, 1992. pp. 1421-1441.

Abdel-Malek ZA, Swope VB, Nordlund JJ: The nature and biological effects of factors responsible for proliferation and differentiation of melanocytes. In: The Pigment Cell: From the Molecular to the Clinical Level. Proceedings of the XIV International Pigment Cell Conference, Kobe, Japan, Y Mishima (ed), Munksgaard, Copenhagen, 1992. pp. 43-47.

Nordlund JJ: The significance of depigmentation. Pigment Cell Res Suppl 2:237-241, 1992.

Nordlund JJ: Reply: Melagenina and Vitiligo (Letter to the Editor). Dermatology 184:154-155, 1992.

Nordlund JJ: The pigmentary system and inflammation. Pigment Cell Res 5:362-365, 1992.

Nordlund JJ, Halder RB, Grimes P: Management of vitiligo. Dermatol Clinics 11:27-33, 1993.

Pelc NJ, Nordlund JJ: Pigmentary Changes in the Skin. An Introduction for Surgeons. In: Clinics in Plastic Surgery, MH McGrath, ML Turner (eds), W.B. Saunders Co., Philadelphia, PA, 20:53-60, 1993.

Shah AS, Supapannachart N, Nordlund JJ: Acquired hypomelanotic disorders. In: Pigmentation and Pigmentary Disorders, N Levine (ed), CRC Press, Boca Raton, FL, 1993. pp. 337-361.

Nordlund JJ, Breneman DL, Pelc NJ, King AD: Melanoma, Kaposi's sarcoma and mycosis fungoides. In Textbook of Medicine, Stein J, Hutton JJ, et. al. (eds), Mosby YearBook, Inc., St. Louis, 1993. pp. 919-924.

Nordlund JJ: Melanin and Melanogenesis. G. Prota Review. J Am Acad Dermatol 1993.

Nordlund JJ: The pigmentary system: an expanded perspective. Ann Dermatol 6:109-123, 1994.

Leikauf GD, Abdel-Malek ZA, Swope VB, Doupnik CA, Nordlund JJ: Constitutive biosyn­thesis of 12-hydroxy'5,8,10,14-eicosatetraenoic acid and 6-keto prostaglandin F1a by human melanocytes and Cloudman S91 melanoma cells. In: Prostaglandins, Leukotrienes and Cancer, S Hammerström, LW Marnett (eds), Kluwer Academic Press, Boston, 1994. (in press).

Boissy RE, Nordlund JJ: Biology of melanocytes. In: Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, KA Arndt, PE LeBoit, JK Robinson, BU Wintroub (eds), WB Saunders Co., Philadelphia, PA, 1994. (in press)

Boissy RE, Nordlund JJ: Vitiligo. In: Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, KA Arndt, PE LeBoit, JK Robinson, BU Wintroub (eds), WB Saunders Co., Philadelphia, PA, 1994.

Cummings MP, Nordlund JJ: Chemical Leukoderma: Fact or Fancy. Am J Contact Derm 6(2):122-127, 1995.

Nordlund JJ: The pathogenesis of vitiligo vulgaris. A. Alomar (ed), Barcelona, Spain , 1995. (in press)

Nordlund JJ: The pigmentary system: an expanded perspective. Ann Dermatol ( Korea ), 6:109-123, 1994.

Nordlund JJ: Dermatology review questions. In: Family Medicine Review, Venturo AF (ed), Sattinger, Inc., Atlanta, GA, 1994.

Nordlund JJ, Grimes PE, Halder RM, Minus HR: Guidelines of care for vitiligo. Dermatol World Suppl May:28-33, 1995.

Nordlund JJ: Melanin and melanocytes: their function and significance from a clinician's perspective. In: Melanin: Its Role in Human Photoprotection. Zeise L, Chedekel MR, Fitzpatrick TB (eds), Valdenmar Publishing Co., Overland Park, KS, 1995. pp. 183-193.

Nordlund JJ: Pathogenesis of Vitiligo Vulgaris. In: Monografias de Dermatologia, Vol VIII, No 3, JA Ruiz (ed), Groupo Aula Medica, S.A., Madrid, Spain, May/June 1995. pp. 149-164.

Boissy RE, Nordlund JJ: Biology of melanocytes. In: Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, KA Arndt, PE LeBoit, JK Robinson, BU Wintroub (eds), WB Saunders Co., Philadelphia, PA, pp 1203-1209, 1995.

Boissy RE, Nordlund JJ: Vitiligo. In: Cutaneous Medicine and Surgery: An Integrated Program in Dermatology, KA Arndt, PE LeBoit, JK Robinson, BU Wintroub (eds), WB Saunders Co., Philadelphia, PA, pp. 1210-1218, 1995.

Nordlund JJ: Psychosocial effects of vitiligo and the failure of the medical profession. In: Dermatology and Person-Threatening Illness: The Patient, the Family, the Staff. Walther RR, Beachman A, Ginsburg IH (eds), The Haworth Press, Inc., New York, 1996. pp. 113-120.

Nordlund JJ: Psychosocial effects of vitiligo and the failure of the medical profession. In: Dermatology and Person-Threatening Illness: The Patient, the Family, the Staff, Walther RR, Beachman A, Ginsburg IH. The Haworth Press, Inc., pp. 113-120, 1996.

Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Turner ML, Webster SB, Whitaker DC, Lowery BJ, Nordlund JJ, Grimes PE, Halder RM, Minus HR. Guidelines of care for vitiligo. American Academy of Dermatology. J Am Acad Dermatol 35: 620-626, 1996.

Gadenne AS, Nordlund JJ: Pigmentary Disorders. In: Conn's Current Therapy, RE Rakel (ed), WB Saunders Co., Philadelphia, PA, pp. 819-822, 1996.

Nordlund JJ: Autocrine and paracrine control of melanocytes. In: Melanogenesis and Malignant Melanoma: Biochemistry, Cell Biology, Molecular Biology, Pathophysiology, Diagnosis and Treatment, Y Hori, VJ Hearing, J Nakayama (eds), Elsevier, Tokyo, Japan, 1996. pp. 73-76.

Nordlund JJ: Vitiligo. In: Clinical Dermatology, DJ Demis (ed), Lippincott-Raven, Philadelphia, PA, Unit 11-33, pp. 1-16, 1997.

Boissy RE, Nordlund JJ: Molecular Basis of Congenital Hypopigmentary Disorders in Humans - A Review. Pigment Cell Res 10:12-24, 1997.

Nordlund JJ: The Pigmentary System: An Expanded Perspective. In: The Kung-Sun Oh Memorial Lectures 1987-1996, Bang D (ed), The Kung-Sun Oh Memorial Foundation, Yonsei University, Seoul, Korea , 1997. pp. 97-117.

Nordlund JJ and Ortonne JP: The Normal Color of Human Skin. Chapter 34. Pp 475-488. In: The Pigmentary System: Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Ortonne JP and Nordlund JJ: Mechanisms that Cause Abnormal Skin Color. Chapter 35 Pp 489-502 In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ and Ortonne JP: Vitiligo Vulgaris.Chapter 37 Pp. 513-551 In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Focal Dermal Hypoplasia. Chapter 39 Pp. 593-594 In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Hereditary Premature Canities. Chapter 41. Pp 613-614. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Pierre Robin Syndrome. Chapter 617. Pp. 615 In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Hallerman-Streiff Syndrome. Chapter 38 Pp. 576. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ, Levine N, Fulk CS, Rubenzik R: Atrophoderma of Pasini and Pierini. Chapter 57. Pp 836-837. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Morphea and Scleroderma. Chapter 57. Pp. 868-869. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Polyneuropathy, Organomegaly, Endocrinopathy, M Protein and Skin Changes: P.O.E.M.S. Syndrome. Chapter 57. Pp 884.886. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Intestinal Pigmented Anomaly of the Flexures (Cronkhite-Canada Syndrome.) Chapter 57. Pp 865-866. In: The Pigmentary System: Its Physiology and Pathophysiology.

Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Ichthyosis Nigricans, Keratoses and Epidermal Hyperplasia. Chapter 57. Pp. 863-864. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Lamerson C, Nordlund JJ: Pigmentary Changes in Addison's Disease. Chapter 57. Pp. 875-877. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Urticaria Pigmentosum and Mastocytosis. Chapter 57. Pp. 891-894. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ: Nevus Aversion Phenomenon. Chapter 62. Pp. 951 In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Halder R and Nordlund JJ: Topical Treatment of Pigmentary Disorders. Chapter 63. Pp. 969-976. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Halder R and Nordlund JJ: Phototherapy for Pigmentary Disorders. Chapter 64. Pp. 977-984. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund JJ and Halder R: Sunscreens and Cosmetics. Chapter 65. Pp. 985-986. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Halder R and Nordlund JJ: Surgical Treatment of Pigmentary Disorders. Chapter 66. Pp. 987-994. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Halder R and Nordlund JJ: Laser Treatment of Pigmentary Disorders. Chapter 67. Pp. 995-998. In: The Pigmentary System: Its Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-P, (eds), Oxford University Press, New York, NY. 1998.

Nordlund, JJ and Boissy, RE: Biology of Melanocytes. In: The Biology of Skin. Ed. David Woodley, Ruth Frankel. Parthenon Publishing, London, England In press 2000

Nordlund, JJ. The epidemiology and genetics of vitiligo. Clinics in Dermatology. 13: 875-879, 1997.

Cummings, M., Nordlund JJ. Vitiligo in Clinical Dermatology Ed. Joseph Demis. Lippincott-Raven Press, New York, 1997.

Boissy, RE., Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res. 10: 12-24, 1997

Nordlund JJ. Sunscreens and Sun Protection. Pp 218 - 221. In Vitiligo:A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. 2000.

Im SB, Nordlund JJ. Physiological alterations in depigmented skin of patients with vitiligo. Pp 254-268. In Vitiligo: A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. 2000.

Hann SK, Nordlund JJ. The definition of vitiligo.pp 3-6 In Vitiligo: A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. In press 2000.

Nordlund JJ. Depigmentation for the treatment of extensive vitiligo. Pp 207-213 In Vitiligo: A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. In press 2000.

Hann, SK, Nordlund JJ. Clinical Features of Generalized Vitiligo. Pp 35-48. In Vitiligo: A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. In press 2000.

Nordlund JJ, SK Hann. Association of vitiligo with other disorders of other organ systems. Pp 89-96 In Vitiligo: A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. In press 2000.

Nordlund JJ. The loss of melanocytes from vitiliginous skin. The mechanism for depigmentation in vitiligo vulgaris. Pp 7- 12 In Vitiligo: A Monograph on the Basic and Clinical Science. Eds SK Hann and JJ Nordlund. Blackwell Scientific Press. London. In press 2000.

Hann S-K and JJ Nordlund. Symposium on Vitiligo: A Manifestation of Apoptosis? For 17th International Pigment Cell Conference, October 30, 1999. Nagoya, Japan

Nordlund JJ and C Lamerson. Vitiligo. Chapter 14.2 pp 880-891 in Testbook of Pediatric Dermatology. Eds. J Harper, A Oranje and N Prose. Blackwell Science Ltd. 2000 Oxford, England

Boissy RB and JJ Nordlund. Albinism in eMedicine, an electronic textbook. Editor William D. James. Published 2000.

Nordlund, JJ. Vitiligo: Personal Reflections and Concepts. Yale University/Fujisawa Lectureship Series in Dermatology. 2001

Huang, CL, Boissy RB, Nordlund JJ. Vitiligo: manifestation of apoptosis. Am J Clin Dermatol 3: 301-308, 2002.

Nordlund JJ. The Value of Melanin as a Sunscreen. In Mechanisms of Suntanning. Eds. JP Ortonne and R Ballotti. Pp 341-362. Martin Dunitz Ltd, publishers, London. 2002.

Kanzler, MH, LS Davidson, JJ Nordlund, SB Mallory. Dermatology Core Curriculum: Pediatric Dermatology. Kendall/Hunt Publishing Co. Dubuque, IA, 2001.

Fein, H. JJ Nordlund. Neonatal Pigmentation. In Neonatal Skin. Eds. Stephen Hoath and Howard Maibach. Marcel Dekker, Inc, New York. Pp 89-108, 2004

Nordlund JJ Pigmentary Disorders. In Conn Current Therapy 2004. Eds R E Rakel and E T Bope. Saunders, Philadelphia. pp 909-911, 2004.

Liao, Wennie, JJ Nordlund. Differential Diagnosis for Vitiligo. In Vitiligo: Problems and Solutions. Eds. T. Lotti and J Hercogova. Marcel Dekker, New York, pp 207-224, 2004.

Nordlund JJ Segmental vitiligo: a scientific conundrum. Pigmentary Disorders Academy

Abstracts

Nordlund JJ, Root RK, Wolff SM: Studies on the origin of human leukocytic pyrogen (LP). Clin Res 17:373, 1969.

Nordlund JJ, Gershon RK: Lymphocyte tumor cell interactions which regulate clinical appearance of transplantable murine melanoma. J Invest Dermatol 62:544, 1974.

Nordlund JJ, Gershon RK: Effects of the spleen on the immune response to tumor antigens. Clin Res 23:453A, 1975.

Nordlund JJ, Cone R, Gershon RK, Ackles AE: The biphasic effects of tumor associated antigens (TAA) on the host immune response. Clin Res 24:495, 1976.

Lerner AB, Nordlund JJ, Albert DM: Changes in the eyes of patients with vitiligo. N Engl J Med 296:232, 1977.

Nordlund JJ, Lerner AB, Albert DM: Abnormalities in the eyes of patients with vitiligo. J Invest Dermatol 68:241, 1977.

August M, Nordlund JJ, Hsiung GD: Persistence of HSV'1 and HSV'2 in infected individuals. 17th Interscience Conference on Antimicrobial Agents and Chemotherapy. Nov. 1977.

Lerner AB, Nordlund JJ, Kirkwood JM: Effects of oral contraceptives and pregnancy on melanoma. N Engl J Med 301:47, 1977.

August M, Nordlund JJ, Hsiung GD: Comparison of cell culture and fluorescent antibody techniques for typing HSV'1 and HSV'2 isolated from the skin of infected patients. IV International Congress for Virology. The Hague, Netherlands, August, 1978.

Nordlund JJ, Ackles AE, Gershon RK: Quantitative factors which affect the growth rate of Cloudman melanoma. J Invest Dermatol 70:218, 1978.

Halaban R, Nordlund JJ, Franckeu J: Malignancy and pigmented hybrid cybrid and reconstituted cells. Presented Cell Biology Meetings, Dallas, Texas, 1979.

Kirkwood JM, Ariyan S, Mitchell MS, Nordlund JJ, Lerner AB, Papac RJ, Forget BM, Knopf M: Intralymphatic and local regional adjuvant immunotherapy with mercaptoethanol-extracted residue of vacille calmette-guerin in high risk melanoma. Proc Am Assoc Cancer Res and ASCO 21:1120, 1980.

Nordlund JJ, Ackles AE, Traynor FF: A specific method for quantifying cell bearing Ia antigens in murine epidermis. J Invest Dermatol 74:248, 1980.

Ackles AE, Nordlund JJ, Traynor FF: Optimal growth of pigment cells stimulated with psoralens and ultraviolet light. J Invest Dermatol 74:246, 1980.

Nordlund JJ, Todes-Taylor M, Albert DM, Lerner AB: The prevalence of vitiligo in patients with uveitis. Yale J Biol Med 53:447, 1980.

Bystryn JC, Howanitz N, Nordlund JJ: Antibodies to melanocytes in patients with vitiligo. Yale J Biol Med 53:447, 1980.

Nordlund JJ, Ackles AE: The effects of ultraviolet light and certain drugs on murine epidermal Langerhans cells. J Invest Dermatol 76:309, 1981.

Nordlund JJ, Ackles AE: Response of Ia bearing cells in murine skin to contact allergens and melano­cytotoxins. J Invest Dermatol 76:325, 1981.

Howanitz N, Nordlund JJ, Lerner AB, Bystryn JC: Antibodies to melanocytes in patients with vitiligo. J Invest Dermatol 76:323, 1981.

Krown SE, Burk M, Kirkwood JM, Kerr D, Nordlund JJ, Morton DL, Oettgen HF: The American Cancer Society clinical trial of human leukocyte interferon in malignant melanoma: Preliminary results. Proc Int Symp on Clin Immunol 22:628, 1981.

Nordlund JJ, Ackles AE, Sauder D: The proliferative and stimulatory effects of parasubstituted phenols (PSP). J Invest Dermatol 80:350, 1983.

Bookstein R, Halaban R, Shaw H, Nordlund JJ, Forget BM, Lerner AB, Milton G, Kirkwood JM: Analysis of natural antibody to cultured human melanoma and melanocytes. Clin Res 31:403, 1983.

Nordlund JJ, Lerner AB, Moellmann GE, Kirkwood JM, Forget BM: Vitiligo: Some new observations and a reconsideration of its pathogenesis. Presented at American Dermatologic Association Meeting, Sea Island, Georgia , March, 1984.

Nordlund JJ: PUVA and benoquin treatment of vitiligo: A paradox. Proc Jap Soc Invest Dermatol 7:188, 1982.

Scheibner A, Milton GW, McCarthy W, Nordlund JJ: Distribution of Langerhans cells in normal epidermis. J Invest Dermatol 82:418, 1984.

Bell M, Rheins LA, Nordlund JJ: Cytological alterations in the epidermis of the depigmenting C57BL/vivi mouse. J Cell Biol 99:3862, 1984.

Rheins LA, Nordlund JJ: Modulation of the epidermal Langerhans cells: Alterations in contact hypersensitivity reaction to DNFB following application of arachidonic acid. J Invest Dermatol 84:328, 1985.

Nordlund JJ, Rheins LA: Prostaglandin E2 stimulates proliferation of murine epidermal pigment cells. J Invest Dermatol 84:293, 1985.

Amornsiripanitch S, Rheins L, Nordlund JJ: Immunologic abnormalities occurring in the spontaneously depigmenting C57BL/6 vitvit mouse. J Invest Dermatol 86:460, 1986.

Abdel-Malek Z, Collins C, Swope V, Amornsiripanitch N, Nordlund JJ: Effects of prostaglandins (PG) on epidermal pigment cells (EPC) of DBA/2 mice and on Cloudman melanoma cells. J Invest Dermatol 86:491, 1986.

Rheins LA, Collins CE, Amornsiripanitch S, Nordlund JJ: Cutaneous immune suppression following topical application of the prostaglandin (PG) PGE2. J Invest Dermatol 86:502, 1986.

Moellmann G, Langdon R, Kuklinska E, Nordlund JJ: Langerhans cell associated damage of keratino­cytes in the Hermansky-Pudlack syndrome. J Invest Dermatol 87:156, 1986.

Barnes L, Rheins LA, Nordlund JJ: Restoration of the cutaneous immune response in the spontaneously depigmenting C57BL/Ler-vit/vit (vit/vit) mouse with cyclophosphamide (Cy) and skin grafting. J Invest Dermatol 87:476, 1987.

Rheins LA, Amornsiripanitch N, Young EM, Nordlund JJ: Rapid induction of Thy1 antigenic markers on keratinocytes (KC) and epidermal immune cells in murine skin by topical treatment with antioxidants used in topical medications and in foods. J Invest Dermatol 87:514, 1987.

Abdel-Malek Z, Swope V, Wanzer T, Nordlund J: Modulation of melanoma cell growth and function by prostaglandin E1. J Invest Dermatol 87:474, 1987.

Abdel-Malek ZA, Swope VB, Trinkle L, Boissy RE, Nordlund JJ: Importance of the cell cycle and cyclic AMP for regulation of melanogenesis in Cloudman melanoma cells. J Invest Dermatol 90:543, 1988.

Böhmer U, Trinkle LS, Nordlund JJ, Rheins LA: Beta-lipotropin (b-LPH) activity is associated with Thy'1 positive dendritic epidermal cells (Thy-1+ DEC) in C57BL/6 mice. J Invest Dermatol 90:548, 1988.

Boissy RE, Trinkle L, Nordlund JJ: Characterization and separation of pigmented and albino melano­cytes using flow cytometry. J Invest Dermatol 90:548, 1988.

Hoath SB, Sneller DL, Pickens WL, Nordlund JJ: In vitro epidermal coiling: A bioassay of epidermal retractile elements? J Invest Dermatol 90:565, 1988.

Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ: A new role for epidermal thymocyte activating factor as a modulator of a non-immunologic epidermal function. J Invest Dermatol 90:611, 1988.

Rheins LA, Cotleur AL, Kleier RS, Hoppenjans WB, Sauder DN, Nordlund JJ: Alpha-melanocyte stimulating hormone acts as an immune modulator of the contact hypersensitivity response in C57BL/6 mice. J Invest Dermatol 90:601, 1988.

Abdel-Malek ZA, Swope V, Doupnik C, Leikauf G, Nordlund JJ: Eicosanoids function as autocrine factors in malignant and normal melanocytes. Presented at the Pan American Pigment Cell Society, Bethesda, Maryland, April, 1988.

Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ: New role for epidermal thymocyte activating factor as a modulator of a nonimmunologic epidermal function. Presented at the Pan American Pigment Cell Society, Bethesda, Maryland, April, 1988.

Boissy RE, Tsai YY, Nordlund JJ: Premelanosomal acidity demonstrated by electron immunocytochem­istry. Presented at the Pan American Pigment Cell Society, Bethesda, Maryland, April, 1988.

Abdel-Malek ZA, Swope V, Doupnik C, Leikauf G, Nordlund JJ: Eicosanoids function as autocrine factors in malignant and normal melanocytes. Pigment Cell Res 2:148, 1989.

Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ: New role for epidermal thymocyte activating factor as a modulator of a nonimmunologic epidermal function. Pigment Cell Res 2:152, 1989.

Boissy RE, Tsai YY, Nordlund JJ: Premelanosomal acidity demonstrated by electron immunocytochem­istry. Pigment Cell Res 2:141, 1989.

Abdel-Malek ZA, Swope V, Doupnik C, Leikauf G: Responsiveness of malignant and normal melanocytes to autocrine eicosanoids. Clin Res 37:A714, 1989.

Boissy Re, Trinkle LS, Nordlund JJ: Identification of melanocyte subsets which undergo commitment prior to neural-tube emigration. Clin Res 37:A715, 1989.

Swope VB, Abdel-Malek ZA, Sauder DN, Nordlund JJ: Epidermal cytokines downregulate the melano­genic responsiveness of malignant and normal melanocytes. Clin Res 37:A722, 1989.

Amornsiripanitch S, Nordlund JJ: Messenger RNA specific for proopiomelanocortin (POMC) identified in murine epidermal cells. J Invest Dermatol 92:395A, 1989.

Abdel-Malek Z, Swope V, Boissy R, Nordlund J: Human melanocytes exhibit heterogeneity with respect to melanin content and possibly clonogenicity. J Invest Dermatol 94:501A, 1990. (Clin Res 38:A656, 1990)

Boissy R, Austin L, Beato K, Medrano E, Nordlund J: Growth and cytologic aberrations in melanocytes cultured from a murine model and patients with vitiligo. J Invest Dermatol 94:509A, 1990. (Clin Res 38:A657, 1990)

Chetty BV, Boissy RE, Warden GD, Nordlund JJ: Basement membrane and fibroblast aberration in blisters at the donor, graft, and spontaneously healed sites in burn patients. J Invest Dermatol 94:514A, 1990.

Csato M, Takei F, Nordlund JJ: Low expression of ICAM'1 in the depigmenting C57BL/Ler-vit/vit mice: The probable cause for loss of contact sensitization. J Invest Dermatol 94:516A, 1990.

Fivenson DP, Rheins L, Nordlund JJ, Krull EA: Thy'1 expression and T cell receptor type in mycosis fungoides and benign dermatoses. J Invest Dermatol 94:525A, 1990.

Medrano E, Farooqui J, Boissy R, Nordlund J: Cellular heterogeneity in dysplastic nevi and human melanomas. J Invest Dermatol 94:555A, 1990.

Swope V, Abdel-Malek Z, Nordlund J: IL'1a and tumor necrosis factor-a are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 94:582A, 1990.

Kini P, Dhawan AP, Parikh M, Nordlund J: Non-invasive imaging and analysis of skin lesions for early detection of malignant melanoma. Presented at the 26th Annual Meeting of the Association for the Advancement of Medical Instrumentation. Washington, DC, May 11'15, 1991.

Abdel-Malek ZA, Swope V, Pallas J, Nordlund J: Mitogens for neonatal human melanocytes affect melanogenesis and cAMP concentrations. J Invest Dermatol 96:631, 1991.

Csato M, Kenderessy ASz, Nordlund JJ: Demonstration of inducible CD56/NCAM expression in the normal human epidermis and its absence in ataxia-telangiectasia. J Invest Dermatol 96:573, 1991.

Medrano EE, Farooqui J, Babcock G, Akadiri B, Nordlund JJ: Pleiotropic modifications induced by inflammatory mediators (leukotriene C4) in melanocytes from human adult donors: Implications for physiological proliferation and nevi formation. J Invest Dermatol 96:629, 1991.

Searle EA, Boissy RE, Austin LM, Nordlund JJ: Smyth chicken melanocyte autoantibodies: Cross-species reactivity, in vivo binding, and plasma membrane localization of the antigen(s). J Invest Dermatol 96:631, 1991.

Swope VB, Abdel-Malek ZA, Babcock GF, Skramkoski RM, Nordlund JJ: Adult and neonatal human melanocytes are regulated by epidermal cytokines and synthesize interleukin'1a and b. J Invest Dermatol 96:549, 1991.

Fivenson DP, Nordlund JJ, Douglass MC, Krull EA: Increased gamma/delta T cells and Thy'1 cells in cutaneous T cell lymphoma. Ann NY Acad Sci, 1991.

Boyce ST, Medrano EE, Abdel-Malek ZA, Nordlund JJ: Pigmentation of cultured epithelium by human melanocytes in a composite skin substitute model. American Society for Cell Biology, 1991.

Robb EC, Farooqui J, Boissy R, Warden G, Nordlund J: The role of melanocytes in hyperpigmented split thickness human skin. National Meeting of the American Burn Association, Salt Lake City, Utah, April 1-4, 1992.

Csato M, Kenderessy ASz, Nordlund JJ, Dobozy A: Alpha-melanocyte stimulating hormone is a potent inhibitor of human epidermal cell and polymorphonuclear leukocyte chemotaxis. 8th International Congress of Immunology, Budapest, Hungary , August 23-28, 1992.

Zhao H, Boissy Y, Nordlund JJ, Boissy RE: Melanocytes cultured from a patient with tyrosinase-positive albinism lack TRP-1. Mol Biol Cell 3:A85, 1992.

Boyce ST, Supp AP, Dodick JM, Childress CP, Medrano E, Nordlund JJ: Topical nutrients and incubation media provide conditions for complete engraftment and inhibition of wound contraction by cultured skin grafts with melanocytes applied to athymic mice. American Burn Association, 1992.

Abdel-Malek Z, Swope V, Zhao H, Austin L, Boissy R, Nordlund J: Differential expression of melanogenic enzymes in cultured autologous human melanocytes. IV Meeting of the PanAmerican Society for Pigment Cell Research, Cincinnati, Ohio, June, 1992.

Boyce S, Medrano E, Abdel-Malek Z, Nordlund J: Pigmentation of cultured epithelium by human melanocytes after grafting to athymic mice. IV Meeting of the PanAmerican Society for Pigment Cell Research, Cincinnati, Ohio, June, 1992.

Swope V, Abdel-Malek Z, Sauder D, Babcock G, Sramkoski M, Nordlund J: Human melanocytes synthesize interleukin-1a and b and IL-1a and b subpopulations were identified. IV Meeting of the PanAmerican Society for Pigment Cell Research, Cincinnati, Ohio, June, 1992.

Zhao H, Abdel-Malek Z, Nordlund JJ, Gerrard JM, Boissy RE: Aberrant trafficking of proteins in melanocytes from Chediak-Higashi syndrome. IV Meeting of the PanAmerican Society for Pigment Cell Research, Cincinnati, Ohio, June, 1992.

Abdel-Malek, Z, Swope V, Boissy R, Austin L, Nordlund J: Differential regulation of melanogenesis in cultured autologous human melanocytes. The National Meeting of the Society for Investigative Dermatology, Baltimore, Maryland, May, 1992.

Boissy RE, Zhao H, Abdel-Malek ZA, Kumar MK, Nordlund JJ: Melanocytes cultured from Chediak-Higashi syndrome express cellular defects. The National Meeting of the Society for Investigative Dermatology, Baltimore, Maryland, May, 1992.

Swope V, Abdel-Malek Z, Babcock G, Sramkoski M, Nordlund J: Human melanocytes can be separated into interleukin-1a and a/b subpopulations. The Natioal Meeting of the Society for Investigative Dermatology, Baltimore, Maryland, May, 1992.

Medrano EE, Park H-Y, Boissy RE, Yang F, Nordlund JJ: Evidence for a maturation-related response to the terminal differentiation inducer cholera toxin in human melanocytes. J Cell Biochem 170:155, 1993.

Abdel-Malek Z, Swope V, Boissy Y, Boissy R, Severs S, Nordlund JJ: Cutaneous hyperpigmentary lesions in neurofibromatosis-1 are not due to a functional or structural defect in the melanocyte. J Invest Dermatol 100:589, 1993.

Boissy RE, Zhao H, Boissy YL, Austin LM, King RA, Nordlund JJ: Melanocytes from a Brown Oculocutaneous albino lack expression of TRP-1 and exhibit reduced insoluble melanin and aberrant tyrosine hydroxylase activity. Pigment Cell Res 6:275-276, 1993.

Zhao H, Nordlund JJ, Boissy RE: Human TRP-1 has tyrosine hydroxylase but no DOPA oxidase activity. Pigment Cell Res 6:280, 1993.

Abdel-Malek Z, Swope V, Boissy Y, Boissy R, Nordlund J: Cutaneous hyperpigmented lesions in neurofibromatosis-1 contain functionally normal melanocytes. Pigment Cell Res 6:304, 1993.

Farooqui J, Boissy R, Elliot J, Robb E, Warden G, Nordlund J: Biochemical and ultrastructural studies on hyperpigmented human skin xenografts. Pigment Cell Res 6:329, 1993.

Boissy RE, Zhao H, Austin LM, Nordlund JJ, King RA: Melanocytes from an individual with brown oculocutaneous albinism lack expression of TRP-1, the product of the human homologue of the murine brown locus. Am J Hum Genet 53(suppl):160, 1993.

Swope V, Babcock G, Nordlund J, Abdel-Malek Z: Autocrine/paracrine regulation of human melanocytes by cytokines. The XVth International Pigment Cell Conference, London, United Kingdom, September, 1993.

Abdel-Malek Z, Swope V, Babcock G, Dawes S, Nordlund J: Biochemical analysis of UVB induced hyperpigmentation of human melanocytes in vitro. The National Meeting of the Society for Investigative Dermatology, Washington, DC, April, 1993.

Farooqui J, Robb E, Warden G, Nordlund J: Split-thickness xenograft from human skin contains a potent epidermal melanogenic inhibitor. American Burn Association Conference, 1993.

Medrano EE, Yang F, Boissy RE, Nordlund JJ, Park H-Y: Terminal differentiation and senescence in the melanocyte: Inability to phosphorylate the mitogen-activated protein kinase (ERK2) selectively defines the two phenotypes. J Invest Dermatol (in press), 1993.

Zhao H, Eling D, Medrano EE, Nordlund JJ, Boissy RE: Retroviral infection with human TRP-1 cDNA upregulates TRP-1 synthesis and stimulates the activity of tyrosinase in human melanoma cells. Pigment Cell Research 3(Suppl):14, 1994.

Farooqui J, Robb E, Boyce ST, Warden G, Nordlund JJ: Isolation of a unique melanogenic inhibitor from human skin xenografts: Initial in vivo and in vitro characterization. J Invest Dermatol 104:739, 1995.

Tripathi RK, Flanders DJ, Young TL, Oetting WS, Ramaiah A, King RA, Boissy RE, Nordlund JJ: Evaluation of MITF locus linkage to human vitiligo and osteopetrosis. Presented at the 3rd Joint Clinical Genetics Meeting, 27th March of Dimes Clinical Genetics Conference, 3rd Annual Meeting of the American College of Medical Genetics, Bethesda, MD, 1995.

Suzuki I, Hearing V, Cone R, Nordlund J, Abdel-Malek Z: Melanotropic hormones stimulate human melanocyte pigmentation and proliferation. The 56th Annual Meeting of The Society for Investigative Dermatology, Chicago, IL, May, 1995.

Zhao H, Zhao Y, Nordlund JJ, Boissy, RE: Cultivation and differential characteristics of human ocular melanocytes derived from the choroid, iris at the retinal pigmented epithelium. Pigment Cell Res 4(Suppl):20. 6th PanAmerican Society for Pigment Cell Research Conference, Kansas City, MO, June, 1995.

Zhao H, Zhao Y, Boissy RE, Nordlund JJ: Ultraviolet irradiation induces downregulation of tyrosinase activity in cultured human choroidal melanocytes and retinal pigmented epithelial (RPE) cells. Pigment Cell Res 4(Suppl):27. 6th PanAmerican Society for Pigment Cell Research Conference, Kansas City, MO, June, 1995.

Abdel-Malek Z, Swope V, Suzuki I, Im S, Medrano EE, Nordlund J, Ollmann M, Barsh G: Paracrine regulation of human melanocytes by a-MSH, endothelin-1, basic FGF, and the agouti protein. The 6th Annual Meeting of The PanAmerican Society for Pigment Cell Research, Kansas City, MO, June, 1995.

Im S, Medrano EE, Mitchell D, Nordlund J, Abdel-Malek Z: The differential responses of human melanocytes from different skin types to UV light are altered by a-MSH. The 6th Annual Meeting of The PanAmerican Society for Pigment Cell Research, Kansas City, MO, June, 1995.

Tripathi RK, Flanders DJ, Young TL, Oetting WS, Ramaiah A, King RA, Boissy RE, Nordlund JJ: Evaluation of MITF locus linkage in human vitiligo and osteopetrosis. 3rd Joint Clinical Genetics Meeting, San Antonio, TX, March, 1996.

Farooqui J, Can G, Boyce S, Nordlund JJ: Expression of Proopiomelanocortin and its peptides in human epidermis and epidermal cell. Jour Invest Derm 106:883A, 1996.

Farooqui J, Grawboski G, Nordlund JJ: Proopiomelanocortin and its peptides are expressed by human epidermis and human melanocytes and keratinocytes. 45th Annual Symposium on the Biology of Skin. Snowmass, Colorado, July 20-24, 1996.

Zhao H, Boissy RE, Nordlund JJ: Down-regulation of human melanogenesis by acetylcholine in culture. Society for Investigative Dermatology Meeting, Washington, DC, April, 1996.

Im S, Nordlund J, Abdel-Malek ZA: The pigmentary effect of UVB light is mediated by epidermal factors that activate the cAMP pathway. Society for Investigative Dermatology Meeting, Washington, DC, April, 1996.

Can G, Abdel-Malek Z, Boyce S, Nordlund J, Farooqui J: Regulation of ACTH, aMSH and b-endorphin expression in cultures of normal human melanocytes and keratinocytes. XVIth International Pigment Cell Conference, Anaheim, CA, October, 1996.

Suzuki I, Tada A, Swope V, Scott G, Im S, Medrano E, Nordlund J and Abdel-Malek Z: Regulation of human melanocytes by the paracrine factors endothelin-1 and a-melanotropin. XVIth International Pigment Cell Conference. Annaheim, CA, 1996.

Suzuki I, Tada A, Ollmann M, Barsh GS, Im S, Lamoreux ML, Hearing VJ, Nordlund JJ and Abdel-Malek ZA: Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to a-melanotropin. XVIth International Pigment Cell Conference, Annaheim, CA, October, 1996.

Im S, Davis MB, Medrano EE, Cornelius J, Babcock G, Nordlund J and Abdel-Malek Z: Effect of a-MSH on the UVB light-induced growth arrest and apoptosis of normal human melanocytes. XVIth International Pigment Cell Conference, Annaheim, CA, October, 1996.

Im S, Tada A, Davis M, Nordlund J and Abdel-Malek Z: The delayed tanning response to UVB light is mediated primarily by stimulation of the cAMP pathway. XVIth International Pigment Cell Conference, Annaheim, CA, 1996.

Suzuki I, Ollman M, Barsh G. Nordlund JJ and Abdel-Malek Z: Paracrine regulation of human melanocytes by the interaction of a-melanotropin with endothelins and agouti signaling protein. Society for Investigative Dermatology Meeting, Washington, DC, April 1996.

Zhao H, Li L, Boissy RE, Nordlund JJ: Effects of autonomic neurotransmitters on human epidermal and ocular melanocytes in culture. XVIth International Pigment Cell Conference, Annaheim, CA, October, 1996.

Farooqui J, Can G, Boyce S, Robb E, Warden G, Nordlund JJ: Proopiomelanocortin and its peptides are expressed in cultured skin substitutes grafted in athymic mice. 29th Annual meeting of American Burn Association, New York City, NY, March 19-22, 1997.

Zhao H, Robb E, Zhao Y, Farooqui J, Boissy R, Warden G, Nordlund J: Studies on the effects of Lactate and LacHydrin® on Human Pigmentary System. Presented at the 55th Annual Meeting of the American Academy of Dermatology, San Francisco, CA, March, 1997.

Zhao H, Zhao Y, Boissy RE, Nordlund JJ: Effects of lactate on the melanogenesis of human neonatal melanocytes in culture. Presented at the 55th Annual Meeting of the American Academy of Dermatology, San Francisco, CA, March, 1997.

Zhao H, Boissy RE, Good WV, Nordlund JJ: Ocular melanocytes express b-adrenergic receptor and respond to autonomic neurotransmitters. Invest Ophthalmol Vis Sci (in press). ARVO Conference, Ft. Lauderdale, FL, May, 1997.

Nordlund JJ. Vitiligo in Tanzania . International Pigment Cell Conference. Nagoya, Japan , 1999.